Alzheimer'S Disease Clinical Trials in Miami, FL

Alzheimer'S Disease Clinical Trials in Miami, FL

View the best 10 alzheimer's disease medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Alzheimer'S Disease clinical trial.

Top rated alzheimer's disease clinical trials in Miami, Florida

Here are the top 10 medical studies for alzheimer's disease in Miami, Florida

Image of Xenoscience in Phoenix, United States.

ALZ-801

Small Molecule

Recruiting1 awardPhase 3
This trial is testing a potential Alzheimer's treatment in people with a specific gene type. It is double-blind, meaning neither the participants nor the researchers know who is receiving the treatment or the placebo.
Image of Science Connections, LLC in Doral, United States.

AVP-786

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial is for participants who have completed other similar trials. It allows people from the Phase 2 Study to be included.
Image of Ah0003 50428 in Fresno, United States.

Bepranemab

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing if a new drug, bepranemab, can help people with prodromal or mild Alzheimer's Disease by improving their cognitive function.
Image of University of Alabama, Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial will test whether lecanemab is better than placebo at improving cognition and reducing brain amyloid accumulation in people with Alzheimer's disease.
Image of Novo Nordisk Investigational Site in Fullerton, United States.

Semaglutide +1 More

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is testing whether semaglutide has a positive effect on early Alzheimer's disease by comparing it to a placebo. There will be 17 clinic visits and 1 phone call with the study doctor, and various tests and scans will be performed. The study will last for up to 173 weeks.
Image of MDFirst Research in Chandler, United States.

Simufilam

Recruiting1 awardPhase 3
This trial will study the safety and effectiveness of simufilam, a drug for Alzheimer's disease, for one year. 750 people with mild-to-moderate Alzheimer's will be given the drug or a placebo twice daily. The trial will assess cognitive enhancement and functional decline.
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial will test a new drug, donanemab, for safety and effectiveness in people with early Alzheimer's disease.
Image of Optimus U Corporation in Miami, United States.

Allopregnanolone +1 More

Neurosteroid

Recruiting0 awardsPhase 2
This trial will test if a drug can safely and effectively treat Alzheimer's disease.
Image of JEM Research LLC in Atlantis, United States.

RO7126209

Monoclonal Antibodies

Recruiting0 awardsPhase 1 & 2
This trial will study the safety and effectiveness of an experimental drug for Alzheimer's disease.
Image of Irvine Clinical Research Center in Irvine, United States.

LY3372689 +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new drug for Alzheimer's Disease. It is checking to see if the drug is safe, tolerated and effective.

Popular filter options for alzheimer's-disease miami trials

Phase 3 Clinical Trials

View 56 phase 3 medical studies.

Clinical Trials With No Placebo

View 56 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.